|
Search & win prizes instantly - Join iRazoo Now! |
|
|
cx717
websites
|
Currently popular top ten sites for: cx717
|
|
|
|
|
|
|
|
#1
CX717 - Wikipedia, the free encyclopedia CX717 is an ampakine compound created by Christopher ... "FDA's Psychiatric Division has Rejected Cortex's Request to Study CX717 in Phase IIb ADHD Study" ... en.wikipedia.org
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS%2Bn7ToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeKha%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pbFydd7xuHk3KKk7KCKwsqD1oiqk5PIvM6whLfEr9ymn8mNg6unl8ipmsi5uqbkuH206JKqeLK6rLWV44XcqWO40qJ8npd1&key=tag-38565-0-875157420424&affID=38565&id=LFPvAffVC0&sitehost=en.wikipedia.org
|
|
|
#2
CX717 Information on CX717. ... The drug, CX717, is an ampakine, one of a class of synthetic compounds that ... CX717 may have similar effects in humans. ... www.ampakines.org
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS%2Bk7ToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeLnq%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pZxq6mAxMLh4qud4b%2FKra2UuoWkttuEfJ6adsi548OXhs2Zx7Hoqpdqn6SxjKLFrZGCz9Pbmnukh8aivY2qd2jY25o%3D&key=tag-38565-1-105874225150&affID=38565&id=LFPvAffVC1&sitehost=www.ampakines.org
|
|
|
#3
CX717 Reverses Effects of Sleep Deprivation on Brain CX717 Reverses Effects of Sleep Deprivation on Brain. Aug 24, 2005, 04:15, ... The drug, currently known as CX717, is designed to act on a type of receptor ... www.rxpgnews.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKTBxbToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeKfa%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2paCydd7xuHk3KKk7KCKwsqD1oiqk5N5gb%2FbcsjCxrGCfujKhpnsoolqeMfIx6LOu5aTuKOdZn2YhpXR6q3SjH2wk5e46JWdzK61r5WQ3qK0qMCc2Z90rJvLur20Ypewot6Znryiwc7parhmn9OrtpnaypfJxKXIjqTKzcmuxViWeg%3D%3D&key=tag-38565-2-827067696390&affID=38565&id=LFPvAffVC2&sitehost=www.rxpgnews.com
|
|
|
#4
PharmaLive: Cortex's AMPAKINE Compound, CX717, Achieves Primary ... CX717 prevented the reduction in basal breathing rate induced by alfentanil, in ... The effect of CX717 on the VE55 numerically trended toward reversing, but did ... www.pharmalive.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKTBq7ToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldd5fr2%2FZsucn7ymXqiay5q6d714jKazzcLyq6Ca6eeurZ%2FYoZTQ2WayeWixmLbDu9KAxMLh4qud4b%2FKra2UuoWkttuEfJ6adsi548ONnMGqw4apeZVpZb26mrLCt5GY3KbDdZLtuYGl4oOwqJm5yoyV5t2ilenPqn6Q1qy7hqZ314mMvNmFuqmuhLau3dmif9StgbGqqLdmrJzNnJev1pvLxOXcfGm2qIXSyqiaiVeVp8Fxq6mBd6mynWZ%2B&key=tag-38565-3-182979896307&affID=38565&id=LFPvAffVC3&sitehost=www.pharmalive.com
|
|
|
#5
AMPAKINE Compound, CX717, Achieves Primary Endpoints In Second Phase ... Cortex Pharmaceuticals, Inc. (NYSE Alternext US (COR)) reported that top-line data from its second Phase IIa study in opioid-induced respiratory depression (RD) ... www.medicalnewstoday.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS8ybToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeMtK%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pa1ydd7xuHk3KKk7KCKwsqD1oiqk5N5gb%2FbcsjC08Vpiuekn5Wnja%2BMlNfPopLevnWg6tPDroHonprFqHjPpGrT27WCsLWpm865y2qqmIaVyq2ImqCsta6okt7Qioacn70%3D&key=tag-38565-4-536217509764&affID=38565&id=LFPvAffVC4&sitehost=www.medicalnewstoday.com
|
|
|
#6
Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints in Second ... Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints in Second Phase IIa Respiratory Depression Study in Germany. - IRVINE, Calif.--(BUSINESS WIRE)--Cortex ... biz.yahoo.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS8wbToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeLpq%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pbBydd7xuHk3KKk7KCKwsqD1oiqk5PFu%2BHHe7PE3dunr6uHgdHDmLKomrK5tpbdy6S%2F0dnMoY7WlcnZmWWoWmSny4W3yM6YoPDQxZeAmImXhql52XxztpqZcaupdKe7s%2BhshMOhqcOsaA%3D%3D&key=tag-38565-5-499388400940&affID=38565&id=LFPvAffVC5&sitehost=biz.yahoo.com
|
|
|
#7
News: Cortex's AMPAKINE CX717 Toxicology Data Package Submitted to FDA ... Cortex's AMPAKINE CX717 Toxicology Data Package Submitted to FDA. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business. The Leading ... www.genengnews.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKTBirToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeKfa%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pa9ydd7xuHk3KKk7KCKwsqD1oiqk5N5gb%2FbcsjC0etpmuikhoamd5dqn6jEw57aq5WLwrmdZn3cxMa14niwqIeo0cOS69yRieLR4W2G2KyzlKyK3GmjlIiGkMKudKCcn7ylhOmtt9DggZqFZNLdxL3brZXE6efchp%2FGwqTL&key=tag-38565-6-517578558672&affID=38565&id=LFPvAffVC6&sitehost=www.genengnews.com
|
|
|
#8
BioWorld Today Although CX717 has had toxicity issues, the Phase IIa ADHD trial showed that a ... A subsequent trial of CX717 in alertness during night shift work didn't enhance ... www.bioworld.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS%2Fk7ToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeIuK%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fFzad%2B6Z6RxuHk3KKk7KCKwsqD1oiqk5N5gb%2FbcsjC0LB%2Bm%2BTKitOnjc6Zl9a5qaLfqnGi0ZKten%2FrwZyrvWuxmWO8k8HDr89ls6q%2FxJmNy8DEtaSGl5yCp72bkbCdprPQved2kaqkg5LeZ96oebG2tcbImqWm4ee%2FpJq0eYan54ioeZvLq6G1sZlmrMrP0KKFubrJyLp6q4Voz7GXca6rlXess7lsquKfiLjhpLSMfbOUqLbgimKXnJ%2B9&key=tag-38565-7-837430598181&affID=38565&id=LFPvAffVC7&sitehost=www.bioworld.com
|
|
|
#9
DARPA To Sponsor Evaluation Of The AMPAKINE CX717 ... Agency (DARPA) of the U.S. Department of Defense is sponsoring a new CX717 study. ... Three different doses of CX717 will be compared to placebo in ... www.spacewar.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS8ybToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeLlq%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pafydd7xuHk3KKk7KCKwsqD1oiqk5N5gb%2FbcsjCxuyoj%2BnKp9akfJuZl9a5qaLe3HGhwd6%2FfrHGwaKZuYnSaYfQ3Lac8a6pk8%2FGzIxv4pibsup02YN8tamkt8qKYpecn70%3D&key=tag-38565-8-196865665727&affID=38565&id=LFPvAffVC8&sitehost=www.spacewar.com
|
|
|
#10
TO OUR SHAREHOLDERS AND FRIENDS: As 2005 comes to a close I find that ... ment of CX717 and all of us at the company eagerly awaiting the results from our ... IIa clinical trials for CX717. ... CX717. ... www.cortexpharm.com
http://feed.validclick.com/gen.php?dst=vMXV5G2TZKTGlIZ66NuVxOvi6pln1sO%2BkNhi16dhotu1vuDYbYOsuMieoKS8hrToaMWqqdjJhJiemna7z7LapY7ey8ij4GjdbWual7WPw655mrDHz1lrt5yb0smDvaqCxJqWxZ6adqjAz51mfaTBvs%2Bnh9qrl7bMtY7itKHMqdudaX%2FgqZayqoS1emSvqnmBv7ylu8C00JyS6oyew%2BKqqHZ4ldeLoq%2FeVYS7351pf%2B2Nl6XNdr54gtzZzZLpraLMrebemYa2w7aUwneag2fF2pbF05tmk6fnxVlrt7u9hqZ31HyIs5mtfOSWnsi54syEcdu2w4amd7Ztq7zctrHHzYWoxrLDfazVrsmUuInGWmepm8Nxq6mlyr%2Fl2oxwzMKjqdWhyqKi0JuewLvXhbXgxu2mhJiJl9TIf5xaZKg%3D&key=tag-38565-9-269361623008&affID=38565&id=LFPvAffVC9&sitehost=www.cortexpharm.com
|
|
|
|
People Recommended Results
|
|
We want you to become a Razoo Reviewer. Please recommend a website you liked for
this keyword. |
|
|
|
|
|
|
|
|